Orphee SA is a Switzerland-based company engaged in development and marketing of instrumentation for the haematology diagnostics. The Company operates in over 100 countries worldwide, including Brazil, Bangladesh, China, Philippines, Mexico, Romania, Poland, among others, and is primarily engaged in in-vitro diagnostics (IVD) market. It divides its business into three segments: Sale and Production of Haematology and Electrolyte Analyzers, offering six types of analyzers under the name Mythic (Mythic 18, Mythic 18 Vet, Mythic 22 OT, Mythic 22 CT, Mythic 22 AL, Mythic Lyte); Sale and Production of Blood Test Reagents, and Sale of Spare Parts for Offered Analyzers. The Company is a subsidiary of PZ Cormay SA. On September 1, 2014, the Company acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee.
More about the company